Emergent Devices
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Professional Dr Ste 400, Gaithersbur...Website
www.narcan.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Emergent Devices
Emergent Devices Inc., headquartered in Plymouth Meeting, PA, provides NARCAN Nasal Spray, an over-the-counter medicine used to rapidly reverse the effects of life-threatening opioid overdose emergencies. A wholly-owned subsidiary of Emergent BioSolutions Inc., the company serves consumers, healthcare professionals, and qualified public entities, including government agencies, first responders, schools, and universities. The product is delivered as a nasal spray device containing naloxone, which is available for purchase in stores, online, and through a discounted channel for public entities called NARCANDirect. The company focuses on opioid emergency preparedness and the distribution of naloxone to reduce response times during overdoses.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emergent Devices your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Emergent Devices has new funding data
Product Launch: Get notified when Emergent Devices launches new products
Earning: See what the market has to say on Emergent Devices recently announced quarterly report
Emergent Devices, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Emergent Devices has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Emergent Devices had a recent Job posting/layoffs
Check out if Emergent Devices is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Emergent Devices
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Emergent Devices
Compare insights from companies similar to Emergent Devices, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Emergent Devices
$5.3M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Emergent Devices is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Emergent Devices is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Emergent Devices.
Emergent Devices Tech Stack
A closer look at the technologies used by Emergent Devices
Emergent Devices News & Media
Get your Narcan! Old newspaper boxes are being used to distribute overdose reversal drug
Old newspaper boxes are being repurposed into containers that distribute Narcan, an emergency treatment to reverse drug overdoses.Go 4 It: How Narcan reverses opioid overdoses
Narcan, also known as Naloxone, is a critical tool to fight overdoses. It rapidly reverses the potentially fatal effects of opioids in the body, but how does it do that?Nonprescription Naloxone Available for Retail Sales - National Governors Association
Nonprescription availability is an important milestone for states and territories, community organizations, harm reduction advocates, those working to prevent overdose, and people at risk for overdose.Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE:EBS) announced the U.S. Food and Drug Administration (FDA) Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee have unanimously voted in favor (a total of 19 votes) that the benefit-risk profile of NARCAN® (naloxone HCl) Nasal Spray is supportive of its use as a nonprescription opioid overdose reversal agent. Emergent presented an overview of its ove
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emergent Devices
Sign Up For FreeTo access detailed company insights
Emergent Devices Inc., headquartered in Plymouth Meeting, PA, provides NARCAN Nasal Spray, an over-the-counter medicine used to rapidly reverse the effects of life-threatening opioid overdose emergencies. A wholly-owned subsidiary of Emergent BioSolutions Inc., the company serves consumers, healthcare professionals, and qualified public entities, i... Read More
